These data clearly documented that iptacopan treatment results in better control on MAC‐mediated intravascular hemolysis and full prevention of C3‐mediated extravascular hemolysis even when used in monotherapy in PNH patients. The gene discussed is C3; the disease is paroxysmal nocturnal hemoglobinuria.